FT Global Pharmaceutical and Biotechnology Conference, 2017

Home

Coming up

Become a sponsor

Past events

What we do

Healthcare & Life Sciences

FT Global Pharmaceutical and Biotechnology Conference Thriving Amid Uncertainty London | 09 - 10 November 2017 Speakers include: Kemal Malik Bayer

David Meek Ipsen

BelĂŠn Garijo The Merck Group Register Now

Presented By

With the Support Of

Lead Sponsors

Associate Sponsors

OVERVIEW The FT Global Pharmaceutical and Biotechnology Conference, now in its 35th successful year brings together life science companies, their health industry counterparts and emerging new industry entrants to review the key challenges facing the industry, W ith PDFmyURL anyone can convert entire websites to PDF!

Add to my Calendar Days until event:

Search by

and the business models and transformation strategies that will be needed to survive and thrive in this new era of unprecedented disruption and uncertainty.

FULL OVERVIEW SPEAKERS (61) EXECUTIVE SUMMARY

Download now

Kemal Malik Member of the Board of Management Bayer See bio

David Meek CEO Ipsen See bio

Belén Garijo Member of the Board and CEO, Healthcare The Merck Group See bio

The Rt Hon George Freeman, Minister for Life Sciences UK

CHAIRS AND MODERATORS (3)

David Crow Senior US Business Correspondent Financial Times See bio

“This FT conference has become an annual leadership forum on the international stage, it’s a really important event for London and the UK.”

Sarah Neville Global Pharmaceuticals Editor Financial Times See bio

AGENDA - 9TH NOV W ith PDFmyURL anyone can convert entire websites to PDF!

Greg Reh Global Life Sciences & Health Care Industry Leader Deloitte See bio

“The FT is always at the centre of what goes on in the industry. It’s a great source for all kinds of information and this conference for me is a great way to keep up with the trends and figure out what’s going on in the industry.” Dr Flemming Ornskov, Chief Executive Officer, Shire “Great conference to get an update on the strategic direction of global pharma from senior decision makers.”

AGENDA - 10TH NOV WHY ATTEND? WHO ATTENDS?

Emily Lekkas, Scottish Development International “A very relevant event for pharma/biotech, investors and industry observers.” Guy Martin, The Pharma Letter

PRESENTED BY (1) WITH THE SUPPORT OF (1) LEAD SPONSOR (2)

“The conference offers a tremendous opportunity to learn perspectives and insights on business models and medical value.” Tim Durham, Takeda Pharmaceuticals

ASSOCIATE SPONSORS (3) SUPPORTING PARTNERS (5) CONTACT VENUE ACCOMMODATION